|
|
||||||||
The FASEB Journal, Vol 10, 574-586, Copyright © 1996 by The Federation of American Societies for Experimental Biology
REVIEWS |
ME Medof, S Nagarajan and ML Tykocinski
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Protein engineering of cell surfaces is a potentially powerful technology through which the surface protein composition of cells can be manipulated without gene transfer. This technology exploits the fact that proteins that are anchored by glycoinositol phospholipids (GPIs), when purified and added to cells in vitro, incorporate into their surface membranes and are fully functional. By substituting 3'-mRNA end sequence of naturally GPI-anchored proteins (i.e., a sequence that contains the signals that direct GPI anchoring) for endogenous 3'-mRNA end sequence, virtually any protein of interest can be expressed as a GPI-anchored derivative. The GPI-anchored product then can be purified from transfectants and the purified protein used to "paint" any target cell. Such protein engineering or "painting" of the cell surface offers several advantages over conventional gene transfer. Among these advantages are that 1) GPI-anchored proteins can be painted onto cells that are difficult to transfect, 2) cells can be altered immediately without previous culturing, 3) the amount of protein added to the surface can be precisely controlled, and 4) multiple GPI-anchored proteins can be sequentially or concurrently inserted into the same cells. Emerging applications for the technology include its use for the analysis of complex cell-surface interactions, the engineering of antigen presenting cells, the development of cancer vaccines, and possibly the protection against graft rejection.
This article has been cited by other articles:
![]() |
C. Metzner, M. M. Mostegl, W. H. Gunzburg, B. Salmons, and J. A. Dangerfield Association of glycosylphosphatidylinositol-anchored protein with retroviral particles FASEB J, August 1, 2008; 22(8): 2734 - 2739. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Paulick, M. B. Forstner, J. T. Groves, and C. R. Bertozzi A chemical approach to unraveling the biological function of the glycosylphosphatidylinositol anchor PNAS, December 18, 2007; 104(51): 20332 - 20337. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Bowles, I. Wilkinson, R. A. G. Smith, A. J. G. Moir, H. Montgomery, and R. J. M. Ross Membrane Reinsertion of a Myristoyl-Peptidyl Anchored Extracellular Domain Growth Hormone Receptor Endocrinology, February 1, 2007; 148(2): 824 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Baron, A. C. Magalhaes, M. A. M. Prado, and B. Caughey Mouse-Adapted Scrapie Infection of SN56 Cells: Greater Efficiency with Microsome-Associated versus Purified PrP-res J. Virol., March 1, 2006; 80(5): 2106 - 2117. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Notohamiprodjo, R. Djafarzadeh, A. Mojaat, I. von Luttichau, H.-J. Grone, and P. J. Nelson Generation of GPI-linked CCL5 based chemokine receptor antagonists for the suppression of acute vascular damage during allograft transplantation Protein Eng. Des. Sel., January 1, 2006; 19(1): 27 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-y. Wang, R. Leventis, and J. R. Silvius Artificially Lipid-anchored Proteins Can Elicit Clustering-induced Intracellular Signaling Events in Jurkat T-Lymphocytes Independent of Lipid Raft Association J. Biol. Chem., June 17, 2005; 280(24): 22839 - 22846. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Heeger, P. N. Lalli, F. Lin, A. Valujskikh, J. Liu, N. Muqim, Y. Xu, and M. E. Medof Decay-accelerating factor modulates induction of T cell immunity J. Exp. Med., May 16, 2005; 201(10): 1523 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Sloand, L. Mainwaring, K. Keyvanfar, J. Chen, J. Maciejewski, H. G. Klein, and N. S. Young Transfer of glycosylphosphatidylinositol-anchored proteins to deficient cells after erythrocyte transfusion in paroxysmal nocturnal hemoglobinuria Blood, December 1, 2004; 104(12): 3782 - 3788. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Beumer, M. Wulferink, W. Raaben, D. Fiechter, R. Brands, and W. Seinen Calf Intestinal Alkaline Phosphatase, a Novel Therapeutic Drug for Lipopolysaccharide (LPS)-Mediated Diseases, Attenuates LPS Toxicity in Mice and Piglets J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 737 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Debierre-Grockiego, N. Azzouz, J. Schmidt, J.-F. Dubremetz, H. Geyer, R. Geyer, R. Weingart, R. R. Schmidt, and R. T. Schwarz Roles of Glycosylphosphatidylinositols of Toxoplasma gondii: INDUCTION OF TUMOR NECROSIS FACTOR-{alpha} PRODUCTION IN MACROPHAGES J. Biol. Chem., August 29, 2003; 278(35): 32987 - 32993. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Baron and B. Caughey Effect of Glycosylphosphatidylinositol Anchor-dependent and -independent Prion Protein Association with Model Raft Membranes on Conversion to the Protease-resistant Isoform J. Biol. Chem., April 18, 2003; 278(17): 14883 - 14892. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Hung, J.-J. Yu, K. R. Seshan, U. Reichard, and G. T. Cole A Parasitic Phase-Specific Adhesin of Coccidioides immitis Contributes to the Virulence of This Respiratory Fungal Pathogen Infect. Immun., July 1, 2002; 70(7): 3443 - 3456. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagarajan and P. Selvaraj Glycolipid-anchored IL-12 Expressed on Tumor Cell Surface Induces Antitumor Immune Response Cancer Res., May 1, 2002; 62(10): 2869 - 2874. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Bernard and T. K. Woodruff Inhibin Binding Protein in Rats: Alternative Transcripts and Regulation in the Pituitary across the Estrous Cycle Mol. Endocrinol., April 1, 2001; 15(4): 654 - 667. [Abstract] [Full Text] |
||||
![]() |
J.-H. Huang and M. L. Tykocinski CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells Int. Immunol., April 1, 2001; 13(4): 529 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Brodbeck, C. Mold, J. P. Atkinson, and M. E. Medof Cooperation Between Decay-Accelerating Factor and Membrane Cofactor Protein in Protecting Cells from Autologous Complement Attack J. Immunol., October 1, 2000; 165(7): 3999 - 4006. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Geho, J. D. Fayen, R. M. Jackman, D. B. Moody, S. A. Porcelli, and M. L. Tykocinski Glycosyl-Phosphatidylinositol Reanchoring Unmasks Distinct Antigen-Presenting Pathways for CD1b and CD1c J. Immunol., August 1, 2000; 165(3): 1272 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schroter, P. Derr, H. S. Conradt, M. Nimtz, G. Hale, and C. Kirchhoff Male-specific Modification of Human CD52 J. Biol. Chem., October 15, 1999; 274(42): 29862 - 29873. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. McHugh, S. Nagarajan, Y.-C. Wang, K. W. Sell, and P. Selvaraj Protein Transfer of Glycosyl-phosphatidylinositol-B7-1 into Tumor Cell Membranes: A Novel Approach to Tumor Immunotherapy Cancer Res., May 1, 1999; 59(10): 2433 - 2437. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ferguson The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research J. Cell Sci., January 9, 1999; 112(17): 2799 - 2809. [Abstract] [PDF] |
||||
![]() |
G. Cai, T. Michigami, T. Yamamoto, N. Yasui, K. Satomura, M. Yamagata, M. Shima, S. Nakajima, S. Mushiake, S. Okada, et al. Analysis of Localization of Mutated Tissue-Nonspecific Alkaline Phosphatase Proteins Associated with Neonatal Hypophosphatasia Using Green Fluorescent Protein Chimeras J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3936 - 3942. [Abstract] [Full Text] |
||||
![]() |
A. Anumanthan, A. Bensussan, L. Boumsell, A. D. Christ, R. S. Blumberg, S. D. Voss, A. T. Patel, M. J. Robertson, L. M. Nadler, and G. J. Freeman Cloning of BY55, a Novel Ig Superfamily Member Expressed on NK Cells, CTL, and Intestinal Intraepithelial Lymphocytes J. Immunol., September 15, 1998; 161(6): 2780 - 2790. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Makrides Therapeutic Inhibition of the Complement System Pharmacol. Rev., March 1, 1998; 50(1): 59 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Ralton and M. J. McConville Delineation of Three Pathways of Glycosylphosphatidylinositol Biosynthesis in Leishmania mexicana. PRECURSORS FROM DIFFERENT PATHWAYS ARE ASSEMBLED ON DISTINCT POOLS OF PHOSPHATIDYLINOSITOL AND UNDERGO FATTY ACID REMODELING J. Biol. Chem., February 13, 1998; 273(7): 4245 - 4257. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kraus, M. E. Medof, and C. Mold Complementary Recognition of Alternative Pathway Activators by Decay-Accelerating Factor and Factor H Infect. Immun., February 1, 1998; 66(2): 399 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Wells, R. Anand, F. Wang, and J. Lindstrom Water-soluble Nicotinic Acetylcholine Receptor Formed by alpha 7 Subunit Extracellular Domains J. Biol. Chem., January 9, 1998; 273(2): 964 - 973. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |